Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy (2017)
- Authors:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- DOI: 10.1080/02652048.2017.1370028
- Subjects: NEOPLASIAS PANCREÁTICAS; BIOPOLÍMEROS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Microencapsulation
- ISSN: 0265-2048
- Volume/Número/Paginação/Ano: v. 34, n. 6, p. 582-591, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CHEVALIER, Merari T et al. Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy. Journal of Microencapsulation, v. 34, n. 6, p. 582-591, 2017Tradução . . Disponível em: https://doi.org/10.1080/02652048.2017.1370028. Acesso em: 17 out. 2024. -
APA
Chevalier, M. T., García, M. C., Gonzalez, D., Gomes Filho, S. M., Bassères, D. S., Farina, H., & Alvarez, V. A. (2017). Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy. Journal of Microencapsulation, 34( 6), 582-591. doi:10.1080/02652048.2017.1370028 -
NLM
Chevalier MT, García MC, Gonzalez D, Gomes Filho SM, Bassères DS, Farina H, Alvarez VA. Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy [Internet]. Journal of Microencapsulation. 2017 ; 34( 6): 582-591.[citado 2024 out. 17 ] Available from: https://doi.org/10.1080/02652048.2017.1370028 -
Vancouver
Chevalier MT, García MC, Gonzalez D, Gomes Filho SM, Bassères DS, Farina H, Alvarez VA. Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy [Internet]. Journal of Microencapsulation. 2017 ; 34( 6): 582-591.[citado 2024 out. 17 ] Available from: https://doi.org/10.1080/02652048.2017.1370028 - Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
- Resenha sem título próprio
- Targeting Aurora kinase activity in lung cancer cell driven by oncogenic KRAS impairs lung cancer initiating cell function
- Exploring IKKβ as an anti-angiogenic therapeutic target in KRAS-induced lung cancer
- IKK is a therapeutic target in KRAS-induced lung cancer with disrupted p53 activity
- Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
Informações sobre o DOI: 10.1080/02652048.2017.1370028 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
